Epigallocatechin-3-gallate (EGCG): a potential molecule for the development of therapeutics against emerging SARS-CoV-1, MERS-CoV and SARS-CoV-2 coronaviruses

J Glob Antimicrob Resist. 2021 Sep:26:26-28. doi: 10.1016/j.jgar.2021.05.005. Epub 2021 May 27.

Authors

Jeswin Joseph¹, T Karthika¹, V R Akshay Das¹, V Stalin Raj²

Affiliations

¹ Virology Scientific Research (VSR) Laboratory, School of Biology, Indian Institute of Science Education and Research Thiruvananthapuram (IISER TVM), India.
² Virology Scientific Research (VSR) Laboratory, School of Biology, Indian Institute of Science Education and Research Thiruvananthapuram (IISER TVM), India. Electronic address: stalin@iisertvm.ac.in.

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

COVID-19*
Catechin* / analogs & derivatives
Catechin* / pharmacology
Humans
Middle East Respiratory Syndrome Coronavirus* / genetics
SARS-CoV-2

Substances

Catechin
epigallocatechin gallate